文献速递银屑病与炎症性皮肤病

扁桃体菌群改变通过影响衰老中性粒细胞参与银屑病免疫反应

Tonsillar microbiota alterations contribute to immune responses in psoriasis by skewing aged neutrophils.
PubMed 文献 · Br J Dermatol · 2025-01-01

该研究对比24名健康对照与28例银屑病患者的扁桃体菌群,发现患者菌群多样性与组成显著改变,Rothia mucilaginosa减少与全身炎症及病情严重度呈负相关。宏基因组提示短链脂肪酸(SCFA)产生通路受损,患者血清SCFA水平显著降低;功能实验显示SCFA可抑制中性粒细胞衰老、促炎细胞因子分泌及中性粒细胞胞外诱捕网形成。

要点

  • 银屑病患者扁桃体菌群失调,Rothia mucilaginosa减少与炎症和病情严重度负相关。
  • 患者SCFA产生通路受损且血清SCFA水平降低,SCFA可抑制中性粒细胞衰老与促炎反应。
  • 扁桃体菌群及其代谢产物可能通过调节免疫参与银屑病,具潜在临床意义。

核心结论

  • 扁桃体菌群改变及其代谢输出通过调节免疫反应参与银屑病。

研究设计与样本

  • 收集24名健康对照与28例银屑病患者的扁桃体菌群样本,行16S rRNA与宏基因组测序。
  • 采用液相色谱-质谱法测定10名健康对照与14例银屑病患者的血清SCFA水平。
  • 将两组外周血中性粒细胞暴露于代表性微生物代谢物,用功能免疫实验评估关键促炎标志物。

主要发现

  • 银屑病患者扁桃体菌群多样性与组成显著改变,Bacteroidales增多,Burkholderiales、Micrococcales与Pasteurellales减少。
  • Rothia mucilaginosa明显减少,且与中性粒细胞/淋巴细胞比值及银屑病面积和严重度指数呈负相关。
  • 宏基因组分析显示丙酸、丙酮酸与丁酸代谢等SCFA产生关键通路受损,患者血清SCFA水平显著降低。
  • 功能实验显示SCFA抑制中性粒细胞衰老、促炎细胞因子分泌及中性粒细胞胞外诱捕网形成。

临床怎么用

  • 提示扁桃体菌群及SCFA代谢或可作为银屑病炎症评估与干预的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The interplay between microbiota and the onset of immune-mediated diseases is increasingly coming to light. However, the role of tonsillar microbiota in cutaneous inflammation remains largely unknown. OBJECTIVES: To determine how the tonsillar microbiota influences skin inflammation in psoriasis and to uncover the underlying molecular mechanisms. METHODS: Tonsillar microbiota samples were collected from 24 healthy control individuals and 28 patients with psoriasis. Microbial community composition was analysed with 16S rRNA and metagenomic sequencing. Serum levels of short-chain fatty acids (SCFAs) were measured via liquid chromatography-mass spectrometry in 10 healthy control participants and 14 patients with psoriasis. Peripheral blood neutrophils from both groups were then exposed to a representative microbial metabolite and key proinflammatory markers evaluated using functional immune assays. RESULTS: We found significant alterations in the diversity and composition of the tonsillar microbial community in patients with psoriasis, with an increased prevalence of Bacteroidales and a decreased prevalence of Burkholderiales, Micrococcales and Pasteurellales relative to healthy control participants. Notably, a marked reduction in Rothia mucilaginosa correlated inversely with systemic inflammation (neutrophil-to-lymphocyte ratio) and disease severity (Psoriasis Area and Severity Index). Metagenomic analysis revealed disruptions in pathways critical to SCFA production, including propanoate, pyruvate and butanoate metabolism, which was supported by the significantly lower serum SCFA levels found in patients with psoriasis. Functional assays demonstrated that SCFAs inhibited neutrophil ageing, proinflammatory cytokine secretion and neutrophil extracellular trap formation. CONCLUSIONS: Our findings reveal that changes in tonsillar microbiota and their metabolic outputs contribute to psoriasis by modulating -immune responses, with potential clinical implications. Psoriasis is a long-term autoimmune condition. It is characterized by raised red patches of itchy and flaky skin. People with psoriasis often report a sore throat before the onset of symptoms. An imbalance of micro-organisms can trigger worsening of psoriasis. We looked at micro-organisms in the tonsils and how they connect to psoriasis severity. We did this by comparing samples taken from patients with and without psoriasis. We found important differences in micro-organisms between the two groups. Patients with psoriasis had a more complicated mixture of micro-organisms in their tonsils. We also found that patients with psoriasis had less of a specific type of bacteria called ‘R. mucilaginosa’. This reduction was linked to higher levels of inflammation and worse psoriasis. Patients with psoriasis had higher amounts of other types of bacteria and decreases in others. This suggested there was an imbalance in the micro-organisms found in their tonsils. We also confirmed the effects of molecules called ‘short chain fatty acids’ (‘SCFAs’ for short) on the immune system. SCFAs have the ability to prevent older cells in the immune system from working. The differences in micro-organisms found in the tonsils of people with and without psoriasis suggest they have a role in the disease. Micro-organisms in the tonsils could make psoriasis better or worse by affecting the immune system.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Chen J, Liu X, Bai Y, et al. Tonsillar microbiota alterations contribute to immune responses in psoriasis by skewing aged neutrophils. Br J Dermatol. 2025. PMID: 40228816. doi:10.1093/bjd/ljaf134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。